Drugs / Bifidobacterium adolescentis PRL2019
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05737277 | Mar → May 2023 | irritable bowel syndrome | Azienda Ospedaliera "Sant'Andrea" | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bifidobacterium adolescentis PRL2019 | “1 stick containing 20 Mld UFC of Bifidobacterium adolescentis PRL2019 (Gabapral, Pontenure, Italy)” NCT05737277 ↗ |
| Known as | Gabapral | “1 stick containing 20 Mld UFC of Bifidobacterium adolescentis PRL2019 (Gabapral, Pontenure, Italy)” NCT05737277 ↗ |